Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Puriderma appears to be a consumer skincare and over-the-counter scar-care brand rather than a drug-development biotech or pharmaceutical company. Publicly visible product listings indicate that the brand markets topical scar-removal creams, silicone scar sheets, wart-removal products, hydrogel eye masks, and related personal-care items. The available evidence suggests a commercial-stage health and beauty business focused on dermatologic appearance and scar management, with products sold through e-commerce and retail marketplaces rather than a clinical pipeline. I did not find evidence of a therapeutic R&D pipeline, regulated prescription drug development program, or institutional biotech partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Puriderma.